Post hoc AHA 2026 data show the oral GLP-1 receptor agonist lowered systolic blood pressure across hypertension stages, partly beyond weight loss.
|Articles|March 31, 2022
Daily OTC Pearl: Purelax
Author(s)Saro Arakelians, PharmD
Purelax aids in the treatment of occasional constipation and irregularity.
Advertisement
OTC/Lifestyle Pearl of the Day: Purelax
Indication: Purelax aids in the treatment of occasional constipation and irregularity.
Insight:
- Active ingredients: Polyethylene glycol 3350.
- 14 once-daily doses.
- Powder for solution, osmotic laxative.
- Relieves occasional constipation or irregularity and softens stool.
- Do not take more than directed unless advised by a physician.
- The bottle top is a measuring cap marked to contain 17 grams of powder when filled to the indicated line (white section in cap).
- Directions: Adults and children 17 years of age and older: fill to top of white section in cap, which is marked to indicate the correct dose (17 g). Stir and dissolve in 4 to 8 ounces of beverage (cold, hot, or room temperature). Ensure that the powder is fully dissolved before drinking. Do not drink if there are any clumps.
Source
Advertisement
Related to this article
Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Understanding Kratom: Pharmacology, Safety, and Regulation
2
Orforglipron Lowers Systolic BP in ATTAIN-1, ATTAIN-2 Analyses
3
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
4
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
5